VKTX
Viking Therapeutics Inc
27.70$
-2.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +101,647.2% | -4.7% | -99.6% | -100.0% | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1.4% | +1.4% | +2.7% | +1.3% | +1.3% | – | – | -49.3% | +0.0% | +1.4% | +0.0% | +1.4% | +0.0% | +1.4% | +16.0% | +26.4% | – | – | +1.8% | -17.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +25.8% | +33.3% | +5.3% | -6.7% | -12.5% | +0.3% | +71.6% | +8.9% | -10.5% | -11.7% | +63.1% | -28.0% | +22.2% | +23.8% | -2.6% | -8.5% | +27.2% | +27.5% | +11.0% | -15.7% | -8.8% | +27.5% | +7.9% | -11.7% | +35.3% | -32.0% | +26.4% | +32.1% | +11.6% | +17.6% | -1.4% | -4.1% | +36.0% | +33.6% | +45.3% | +49.5% | +70.6% | -2.2% | -22.9% | – | |
| – | -6.0% | +32.2% | -12.1% | -3.2% | +13.6% | +26.4% | -3.3% | +0.2% | +14.1% | +18.6% | -3.2% | -3.4% | +12.1% | +22.3% | -4.6% | -3.5% | -18.7% | +21.5% | +1.6% | -4.7% | +2.1% | +38.6% | +10.8% | +3.6% | -3.1% | +132.1% | +3.1% | -9.5% | -1.2% | +13.5% | +3.2% | +33.9% | +10.7% | -7.7% | +2.4% | -40.3% | +31.0% | +23.9% | +20.5% | – | |
| – | +14.5% | +32.9% | +0.3% | -5.8% | -5.6% | +8.5% | +44.1% | +6.8% | -4.8% | -3.3% | +40.6% | -22.3% | +19.3% | +23.4% | -3.1% | -7.2% | +13.7% | +27.1% | +9.2% | -13.8% | -6.7% | +29.9% | +8.5% | -8.1% | +25.2% | +1.3% | +15.6% | +14.8% | +7.4% | +16.3% | -0.1% | +7.3% | +26.5% | +20.0% | +34.4% | +32.2% | +67.1% | -0.4% | -19.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.4% | +1.0% | +41.4% | -65.0% | +15.1% | -1.1% | -39.1% | -84.2% | +0.0% | +0.0% | +0.0% | +33.3% | +15.0% | -2.2% | -55.6% | +0.0% | +5.0% | +0.0% | +0.0% | – | – | +0.0% | +0.0% | +125.0% | -70.4% | +250.0% | +14.3% | -93.8% | +1,200.0% | +7.7% | -35.7% | +33.3% | +0.0% | +0.0% | +0.0% | -66.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.1% | +0.7% | +43.1% | -64.2% | +6.5% | -63.1% | -301.9% | – | – | – | – | -191.8% | – | -191.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -97.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.